Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes

Stephanie Jones, Peter D. Peng, Shicheng Yang, Cary Hsu, Cyrille J. Cohen, Yangbing Zhao, John Abad, Zhili Zheng, Steven A. Rosenberg, Richard A. Morgan

Research output: Contribution to journalArticle

Abstract

Lentiviral vectors containing promoters of distinct origins, that is, strong viral promoters (cytomegalovirus [CMV] and murine stem cell virus [MSCV]), a cellular promoter (phosphoglycerate kinase [PGK]), and two composite promoters (CAG [a composite promoter sequence comprised of the CMV enhancer and portions of the chicken β-actin promoter and the rabbit β-globin gene] and SV40/CD43), were used to evaluate green fluorescent protein (GFP) reporter gene expression in human primary peripheral blood lymphocytes (PBLs) and tumor-infiltrating lymphocytes (TILs). In PBLs, vectors containing the MSCV promoter were found to be optimal for expression in both minimally stimulated and highly activated lymphocytes. The stability of gene expression was monitored for up to 7 weeks in culture and the MSCV promoter-containing vector was found to be comparable to the cellular PGK promoter-containing vector. The MSCV promoter-containing lentiviral vector was also the most active in transduced TILs and these cells retained biological activity as measured by antimelanoma antigen reactivity. Using the knowledge gained in comparing individual promoters, a series of two-gene-containing lentiviral vectors was constructed in an attempt to produce the α and β chains of antitumor antigen T cell receptors (TCRs). Dual-promoter or internal ribosome entry site (IRES)-containing vector designs were evaluated and found to be unable to produce both chains of the TCR in amounts that led to significant biological activity. In contrast, if the α and β chains were linked by a 2A ribosomal skip peptide, both proper TCR chain pairing and biologically activity were observed. This paper emphasizes the need to optimize both promoter function and protein synthesis in constructs that require stoichiometric production of multiple protein subunits.

Original languageEnglish (US)
Pages (from-to)630-640
Number of pages11
JournalHuman Gene Therapy
Volume20
Issue number6
DOIs
StatePublished - Jun 1 2009
Externally publishedYes

Fingerprint

Tumor-Infiltrating Lymphocytes
T-Cell Receptor Genes
Stem Cells
T-Cell Antigen Receptor
Lymphocytes
Phosphoglycerate Kinase
Viruses
Gene Expression
Muromegalovirus
Globins
Protein Subunits
Green Fluorescent Proteins
Cytomegalovirus
Reporter Genes
Genes
Actins
Chickens
Rabbits
Antigens
Peptides

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes. / Jones, Stephanie; Peng, Peter D.; Yang, Shicheng; Hsu, Cary; Cohen, Cyrille J.; Zhao, Yangbing; Abad, John; Zheng, Zhili; Rosenberg, Steven A.; Morgan, Richard A.

In: Human Gene Therapy, Vol. 20, No. 6, 01.06.2009, p. 630-640.

Research output: Contribution to journalArticle

Jones, S, Peng, PD, Yang, S, Hsu, C, Cohen, CJ, Zhao, Y, Abad, J, Zheng, Z, Rosenberg, SA & Morgan, RA 2009, 'Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes', Human Gene Therapy, vol. 20, no. 6, pp. 630-640. https://doi.org/10.1089/hum.2008.048
Jones, Stephanie ; Peng, Peter D. ; Yang, Shicheng ; Hsu, Cary ; Cohen, Cyrille J. ; Zhao, Yangbing ; Abad, John ; Zheng, Zhili ; Rosenberg, Steven A. ; Morgan, Richard A. / Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes. In: Human Gene Therapy. 2009 ; Vol. 20, No. 6. pp. 630-640.
@article{5aaddb7eae9340d0b86a4a529a347079,
title = "Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes",
abstract = "Lentiviral vectors containing promoters of distinct origins, that is, strong viral promoters (cytomegalovirus [CMV] and murine stem cell virus [MSCV]), a cellular promoter (phosphoglycerate kinase [PGK]), and two composite promoters (CAG [a composite promoter sequence comprised of the CMV enhancer and portions of the chicken β-actin promoter and the rabbit β-globin gene] and SV40/CD43), were used to evaluate green fluorescent protein (GFP) reporter gene expression in human primary peripheral blood lymphocytes (PBLs) and tumor-infiltrating lymphocytes (TILs). In PBLs, vectors containing the MSCV promoter were found to be optimal for expression in both minimally stimulated and highly activated lymphocytes. The stability of gene expression was monitored for up to 7 weeks in culture and the MSCV promoter-containing vector was found to be comparable to the cellular PGK promoter-containing vector. The MSCV promoter-containing lentiviral vector was also the most active in transduced TILs and these cells retained biological activity as measured by antimelanoma antigen reactivity. Using the knowledge gained in comparing individual promoters, a series of two-gene-containing lentiviral vectors was constructed in an attempt to produce the α and β chains of antitumor antigen T cell receptors (TCRs). Dual-promoter or internal ribosome entry site (IRES)-containing vector designs were evaluated and found to be unable to produce both chains of the TCR in amounts that led to significant biological activity. In contrast, if the α and β chains were linked by a 2A ribosomal skip peptide, both proper TCR chain pairing and biologically activity were observed. This paper emphasizes the need to optimize both promoter function and protein synthesis in constructs that require stoichiometric production of multiple protein subunits.",
author = "Stephanie Jones and Peng, {Peter D.} and Shicheng Yang and Cary Hsu and Cohen, {Cyrille J.} and Yangbing Zhao and John Abad and Zhili Zheng and Rosenberg, {Steven A.} and Morgan, {Richard A.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1089/hum.2008.048",
language = "English (US)",
volume = "20",
pages = "630--640",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Lentiviral vector design for optimal T cell receptor gene expression in the transduction of peripheral blood lymphocytes and tumor-infiltrating lymphocytes

AU - Jones, Stephanie

AU - Peng, Peter D.

AU - Yang, Shicheng

AU - Hsu, Cary

AU - Cohen, Cyrille J.

AU - Zhao, Yangbing

AU - Abad, John

AU - Zheng, Zhili

AU - Rosenberg, Steven A.

AU - Morgan, Richard A.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Lentiviral vectors containing promoters of distinct origins, that is, strong viral promoters (cytomegalovirus [CMV] and murine stem cell virus [MSCV]), a cellular promoter (phosphoglycerate kinase [PGK]), and two composite promoters (CAG [a composite promoter sequence comprised of the CMV enhancer and portions of the chicken β-actin promoter and the rabbit β-globin gene] and SV40/CD43), were used to evaluate green fluorescent protein (GFP) reporter gene expression in human primary peripheral blood lymphocytes (PBLs) and tumor-infiltrating lymphocytes (TILs). In PBLs, vectors containing the MSCV promoter were found to be optimal for expression in both minimally stimulated and highly activated lymphocytes. The stability of gene expression was monitored for up to 7 weeks in culture and the MSCV promoter-containing vector was found to be comparable to the cellular PGK promoter-containing vector. The MSCV promoter-containing lentiviral vector was also the most active in transduced TILs and these cells retained biological activity as measured by antimelanoma antigen reactivity. Using the knowledge gained in comparing individual promoters, a series of two-gene-containing lentiviral vectors was constructed in an attempt to produce the α and β chains of antitumor antigen T cell receptors (TCRs). Dual-promoter or internal ribosome entry site (IRES)-containing vector designs were evaluated and found to be unable to produce both chains of the TCR in amounts that led to significant biological activity. In contrast, if the α and β chains were linked by a 2A ribosomal skip peptide, both proper TCR chain pairing and biologically activity were observed. This paper emphasizes the need to optimize both promoter function and protein synthesis in constructs that require stoichiometric production of multiple protein subunits.

AB - Lentiviral vectors containing promoters of distinct origins, that is, strong viral promoters (cytomegalovirus [CMV] and murine stem cell virus [MSCV]), a cellular promoter (phosphoglycerate kinase [PGK]), and two composite promoters (CAG [a composite promoter sequence comprised of the CMV enhancer and portions of the chicken β-actin promoter and the rabbit β-globin gene] and SV40/CD43), were used to evaluate green fluorescent protein (GFP) reporter gene expression in human primary peripheral blood lymphocytes (PBLs) and tumor-infiltrating lymphocytes (TILs). In PBLs, vectors containing the MSCV promoter were found to be optimal for expression in both minimally stimulated and highly activated lymphocytes. The stability of gene expression was monitored for up to 7 weeks in culture and the MSCV promoter-containing vector was found to be comparable to the cellular PGK promoter-containing vector. The MSCV promoter-containing lentiviral vector was also the most active in transduced TILs and these cells retained biological activity as measured by antimelanoma antigen reactivity. Using the knowledge gained in comparing individual promoters, a series of two-gene-containing lentiviral vectors was constructed in an attempt to produce the α and β chains of antitumor antigen T cell receptors (TCRs). Dual-promoter or internal ribosome entry site (IRES)-containing vector designs were evaluated and found to be unable to produce both chains of the TCR in amounts that led to significant biological activity. In contrast, if the α and β chains were linked by a 2A ribosomal skip peptide, both proper TCR chain pairing and biologically activity were observed. This paper emphasizes the need to optimize both promoter function and protein synthesis in constructs that require stoichiometric production of multiple protein subunits.

UR - http://www.scopus.com/inward/record.url?scp=68849130990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68849130990&partnerID=8YFLogxK

U2 - 10.1089/hum.2008.048

DO - 10.1089/hum.2008.048

M3 - Article

C2 - 19265475

AN - SCOPUS:68849130990

VL - 20

SP - 630

EP - 640

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 6

ER -